|Bid||83.29 x 800|
|Ask||85.84 x 900|
|Day's range||83.45 - 85.31|
|52-week range||59.78 - 85.31|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||16.22|
|Earnings date||25 Apr 2023 - 01 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||86.38|
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions record year-over-year sales growth at CER.
CONMED's (CNMD) adjusted fourth-quarter sales and earnings reflect disruption due to implementation of a new warehouse management system.
Cardinal Health's (CAH) fiscal second-quarter results benefit from the solid performance of the Pharmaceutical segment.